In a highly informative conversation with Rahul Koul, Chief Editor, BioVoice News, the Joint Managing Director of Indus Health Plus, Amol Naikawadi shared his insights on the growth of preventive healthcare, pharmacogenomics in India and the potential it holds. The company is a pioneer in preventive healthcare.
About Amol Naikawadi: A Chartered Accountant by training, Mr. Amol Naikawadi has been instrumental in charting out Indus Health Plus’s rapid expansion throughout India. Having piloted the company successfully for almost a decade, he is a proud recipient of the many awards including Asia Pacific Entrepreneurship Award and Bharat Gaurav Award. Amol also happens to be a Member of the FICCI Healthcare Services Committee.
As per Mr Naikawadi, Genes are constant, lifestyle is not. It is important to understand what genes we have inherited. That helps us to make lifestyle changes”
“Incentives and tax benefits on preventive healthcare help in creating awareness. India has the advantage of research and volume. That will help in decreasing the cost of genomic tests” added Mr Naikawadi.
Exclusive interview series presented to you by India’s leading digital news media for the biosciences sector. Follow our YouTube handle @BioVoiceNews for exclusive videos.